Trials / Not Yet Recruiting
Not Yet RecruitingNCT07513207
A Study in Healthy People to Test How Vicadrostat Affects the Heart
Thorough QT Study to Evaluate the Effects of Single Doses of Vicadrostat on Cardiac Safety Parameters in Healthy Male and Female Subjects (a Randomized, Placebo-controlled, Double-blind, Five-period Crossover Study With Open-label Moxifloxacin as Positive Control)
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this trial is to investigate the effect of vicadrostat on the heart compared with placebo in healthy male and female volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vicadrostat | Vicadrostat |
| DRUG | Placebo matching Vicadrostat | Placebo matching Vicadrostat |
| DRUG | Moxifloxacin | Moxifloxacin |
Timeline
- Start date
- 2026-04-22
- Primary completion
- 2026-07-24
- Completion
- 2026-08-21
- First posted
- 2026-04-07
- Last updated
- 2026-04-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT07513207. Inclusion in this directory is not an endorsement.